Medpage Today on MSN5d
Older Immunocompromised Folks May Need More From RSV VaccinesThe adjuvanted RSV prefusion F protein-based vaccine RSVPreF3-AS01E Arexvy was first FDA approved for older adults in May ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity—primarily organ transplant ...
Researchers have shown that people 60 years or older with weakened immunity do not respond as strongly to vaccines against the respiratory syncytial virus (RSV) as people in the same age group with ...
Children at the Jersey Shore are less likely to be fully vaccinated than others across the state. Here's why that worries doctors.
In an exclusive interview with Dr. Rajesh Rajan, a senior cardiologist, insightful directions were shared regarding the Human ...
Johns Hopkins Medicine researchers have shown that people 60 years or older with weakened immunity — primarily organ ...
“We found that on average, older adults who are immunocompromised developed fewer antibodies against RSV following vaccination as compared with the very strong responses for healthy people over ...
In 38 immunocompromised persons who received either the RSVPreF3-AS01E (RSVA-AS01E; Arexvy) or RSVpreF (Abrysvo) vaccine, preF IgG antibody titers rose a median 4.21-fold by 4 weeks -- with 61% of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback